-+ 0.00%
-+ 0.00%
-+ 0.00%

United Laboratories says FDA clears IND for UBT48128 obesity trial

PUBT·08/11/2026 10:09:00
Listen to the news
United Laboratories says FDA clears IND for UBT48128 obesity trial
  • TUL said the FDA cleared INDs for UBT48128 tablets to begin clinical trials in overweight or obesity, plus type 2 diabetes.
  • The IND numbers are 182060 and 182061.
  • UBT48128 is an oral small-molecule GLP-1 receptor agonist.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260811-12280155), on August 11, 2026, and is solely responsible for the information contained therein.